Succinylcholine Chloride Injection, Solution
Product Images NDC 63323-943

4 FDA label images from Fresenius Kabi Usa, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Succinylcholine Chloride (NDC 63323-943). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Suc02 0007 01)

Structural Formula (Suc02 0007 01)
Chemical structure diagram of Succinylcholine Chloride showing its molecular arrangement including quaternary ammonium groups and chloride ions, consistent with its pharmaceutical identity.*
FDA Label Image

Fresenius Kabi Logo (Suc02 0007 02)

FDA Label Image

Package Label (PRINCIPAL DISPLAY -- Succinylcholine Chloride Injection, USP Multiple-Dose Vial Label)

Package Label (PRINCIPAL DISPLAY -- Succinylcholine Chloride Injection, USP Multiple-Dose Vial Label)
Label for Succinylcholine Chloride Injection, USP, 20 mg/mL (200 mg per 10 mL) multiple-dose vial by Fresenius Kabi USA, LLC. The label notes it is sterile, nonpyrogenic, and contains methylparaben and propylparaben preservatives. It is indicated for intravenous or intramuscular use. Storage instructions and warnings about its paralytic effects and need for artificial respiration facilities are included.*
FDA Label Image

Package Label (PRINCIPAL DISPLAY -- Succinylcholine Chloride Injection, USP Multiple-Dose Carton Label)

Package Label (PRINCIPAL DISPLAY -- Succinylcholine Chloride Injection, USP Multiple-Dose Carton Label)
Packaging label for Succinylcholine Chloride Injection, USP, 200 mg per 10 mL (20 mg/mL) by Fresenius Kabi USA, LLC. The label includes warnings about its paralyzing agent effects, storage instructions to keep refrigerated at 2° to 8°C (36° to 46°F), and notes that it is for intravenous or intramuscular use. The label also mentions the product is provided in multiple-dose vials and includes the NDC 63323-943-10 and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.